000291934 001__ 291934
000291934 005__ 20241212090134.0
000291934 0247_ $$2doi$$a10.1093/neuonc/noae128
000291934 0247_ $$2pmid$$apmid:39073785
000291934 0247_ $$2ISSN$$a1522-8517
000291934 0247_ $$2ISSN$$a1523-5866
000291934 0247_ $$2altmetric$$aaltmetric:165778120
000291934 037__ $$aDKFZ-2024-01546
000291934 041__ $$aEnglish
000291934 082__ $$a610
000291934 1001_ $$00000-0002-8597-9128$$aLiu, Anthony P Y$$b0
000291934 245__ $$aSNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.
000291934 260__ $$aOxford$$bOxford Univ. Press$$c2024
000291934 3367_ $$2DRIVER$$aarticle
000291934 3367_ $$2DataCite$$aOutput Types/Journal article
000291934 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733990476_6794$$xReview Article
000291934 3367_ $$2BibTeX$$aARTICLE
000291934 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000291934 3367_ $$00$$2EndNote$$aJournal Article
000291934 500__ $$a2024 Dec 5;26(12):2159-2173
000291934 520__ $$aPineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone to intensive multimodal antineoplastic therapy. Recently, international collaborative studies have shed light on the genomic landscape of these tumors, leading to refinement in molecular-based disease classification in the 5th edition of the World Health Organization (WHO) classification of tumors of the central nervous system. In this review, we summarize the literature on diagnostic and therapeutic approaches, and suggest pragmatic recommendations for the clinical management of patients presenting with intrinsic pineal region masses including parenchymal tumors (pineocytoma, pineal parenchymal tumor of intermediate differentiation, and pineoblastoma), pineal cyst, and papillary tumors of the pineal region.
000291934 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000291934 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000291934 650_7 $$2Other$$aclinical treatment guidelines
000291934 650_7 $$2Other$$apapillary tumor of pineal region
000291934 650_7 $$2Other$$apineal cyst
000291934 650_7 $$2Other$$apineal parenchymal tumors
000291934 650_7 $$2Other$$arisk-stratification
000291934 7001_ $$aLi, Bryan K$$b1
000291934 7001_ $$aVasiljevic, Alexandre$$b2
000291934 7001_ $$aDewan, Michael C$$b3
000291934 7001_ $$aTamrazi, Benita$$b4
000291934 7001_ $$00000-0002-7896-7049$$aErtl-Wagner, Birgit$$b5
000291934 7001_ $$aHansford, Jordan R$$b6
000291934 7001_ $$0P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb$$aPfaff, Elke$$b7$$udkfz
000291934 7001_ $$00000-0003-3302-2719$$aMynarek, Martin$$b8
000291934 7001_ $$aNg, Ho-Keung$$b9
000291934 7001_ $$aTsang, Derek S$$b10
000291934 7001_ $$aGottardo, Nicholas G$$b11
000291934 7001_ $$aGajjar, Amar$$b12
000291934 7001_ $$00000-0002-6832-6539$$aBouffet, Eric$$b13
000291934 7001_ $$00000-0001-5993-8077$$aDufour, Christelle$$b14
000291934 7001_ $$aPizer, Barry$$b15
000291934 7001_ $$00000-0003-1561-9220$$aSchiff, David$$b16
000291934 7001_ $$aJenkinson, Michael D$$b17
000291934 7001_ $$00000-0003-1316-2132$$aLombardi, Giuseppe$$b18
000291934 7001_ $$aWen, Patrick Y$$b19
000291934 7001_ $$00000-0001-5710-5127$$avan den Bent, Martin J$$b20
000291934 7001_ $$aHuang, Annie$$b21
000291934 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noae128$$gp. noae128$$n12$$p2159-2173$$tNeuro-Oncology$$v26$$x1522-8517$$y2024
000291934 909CO $$ooai:inrepo02.dkfz.de:291934$$pVDB
000291934 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000291934 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000291934 9141_ $$y2024
000291934 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-24$$wger
000291934 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000291934 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2023-10-24
000291934 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPädiatrische Gliomforschung$$x0
000291934 980__ $$ajournal
000291934 980__ $$aVDB
000291934 980__ $$aI:(DE-He78)B360-20160331
000291934 980__ $$aUNRESTRICTED